Sensei biotherapeutics to participate in citi's 2024 global healthcare conference

Boston, nov. 27, 2024 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that company management will participate in citi's 2024 global healthcare conference, being held on december 3-5, in miami, fl.
SNSE Ratings Summary
SNSE Quant Ranking